Inhibitory effects of Curcumae Radix carbonisata -based carbon dots against liver fibrosis induced by carbon tetrachloride in mice
Source abstract
Abstract
As a processed product of traditional Chinese medicine Curcumae Radix, Curcumae Radix Carbonisata (CRC) has been widely used in the treatment of liver diseases in ancient medical books. In this study, novel carbon dots (CDs) extending from 1.0 to 4.5 nm were separated from fluid extricates of CRC. Meanwhile, a liver fibrosis model induced by carbon tetrachloride (CCl4) was utilized to determine the inhibitory effects of CRC-CDs against liver fibrosis. The results exhibited the CRC-CDs with a quantum yield of 1.34% have a significant inhibitory effect on CCl4-induced liver fibrosis, as demonstrated by improving hepatocyte degeneration and necrosis, inflammatory cell infiltration and fibrotic tissue hyperplasia, downregulating the levels of alanine transaminase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), direct bilirubin (DBIL), total bile acid (TBA), triglyceride (TG), tumour necrosis factor-α (TNF-α), interleukin (IL)-6 and IL-1β in the serum, upregulating the contents of superoxide dismutase (SOD), reduced glutathione (GSH), and downregulating the concentration of malondialdehyde (MDA), which lays an important foundation for the development of CRC-CDs as a novel drug for the treatment of liver fibrosis, and provide a certain experimental basis for the clinical application of CRC-CDs in the future.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Carbon and Quantum Dots Applications · Curcumin's Biomedical Applications · Pancreatic function and diabetes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People’s Republic of China
School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China
Centre of Scientific Experiment, Beijing University of Chinese Medicine, Beijing, China
Funding
basic research funds for central universities and colleges
References (42)
Show source-provided references
1. 10.3390/cells904087510.3390/cells9040875 ↗
2. 10.3390/cells810124910.3390/cells8101249 ↗
3. 10.1016/j.jep.2019.11244210.1016/j.jep.2019.112442 ↗
4. 10.2147/DDDT.S18672610.2147/DDDT.S186726 ↗
5. 10.1186/s13287-022-02754-x10.1186/s13287-022-02754-x ↗
6. 10.1007/s40263-021-00842-910.1007/s40263-021-00842-9 ↗
7. 10.1021/acsnano.0c0514310.1021/acsnano.0c05143 ↗
8. 10.1007/s00604-020-04328-110.1007/s00604-020-04328-1 ↗
9. 10.1016/j.actbio.2019.12.01510.1016/j.actbio.2019.12.015 ↗
10. 10.3390/pharmaceutics1311198210.3390/pharmaceutics13111982 ↗
11. 10.1016/j.cis.2019.10204610.1016/j.cis.2019.102046 ↗
12. 10.1021/acs.langmuir.0c0296610.1021/acs.langmuir.0c02966 ↗
13. 10.1016/j.jhazmat.2020.12433010.1016/j.jhazmat.2020.124330 ↗
14. 10.2217/nnm-2018-028510.2217/nnm-2018-0285 ↗
15. 10.1186/s12951-021-00847-y10.1186/s12951-021-00847-y ↗
16. 10.2147/IJN.S33888610.2147/IJN.S338886 ↗
17. 10.1166/jbn.2018.265310.1166/jbn.2018.2653 ↗
18. 10.7150/thno.4229110.7150/thno.42291 ↗
19. 10.1039/c9tb02735a10.1039/c9tb02735a ↗
20. 10.1002/smll.20190620610.1002/smll.201906206 ↗
21. 10.2147/DDDT.S28136910.2147/DDDT.S281369 ↗
22. 10.1016/j.msec.2020.11164210.1016/j.msec.2020.111642 ↗
23. 10.1016/j.bios.2016.02.06410.1016/j.bios.2016.02.064 ↗
24. 10.3390/molecules2605124610.3390/molecules26051246 ↗
25. 10.1016/j.jcis.2020.08.12510.1016/j.jcis.2020.08.125 ↗
26. 10.1007/s10895-019-02474-110.1007/s10895-019-02474-1 ↗
27. 10.1039/c9ra04265b10.1039/c9ra04265b ↗
28. 10.1016/j.drudis.2018.01.00610.1016/j.drudis.2018.01.006 ↗
29. 10.1021/acsami.8b1321710.1021/acsami.8b13217 ↗
30. 10.1186/s12951-021-01072-310.1186/s12951-021-01072-3 ↗
31. 10.3389/fphar.2022.81547910.3389/fphar.2022.815479 ↗
32. 10.1186/s12951-017-0296-z10.1186/s12951-017-0296-z ↗
33. 10.1186/s12951-021-00908-210.1186/s12951-021-00908-2 ↗
34. 10.2147/IJN.S28951510.2147/IJN.S289515 ↗
35. 10.3748/wjg.v20.i23.726010.3748/wjg.v20.i23.7260 ↗
36. 10.3748/wjg.v22.i48.1051210.3748/wjg.v22.i48.10512 ↗
37. 10.1016/j.fct.2016.04.02410.1016/j.fct.2016.04.024 ↗
38. 10.14670/HH-11-72010.14670/HH-11-720 ↗
39. 10.1016/j.jphs.2018.01.00310.1016/j.jphs.2018.01.003 ↗
40. 10.1016/j.ejphar.2016.04.04210.1016/j.ejphar.2016.04.042 ↗
41. 10.1016/j.intimp.2020.10666210.1016/j.intimp.2020.106662 ↗
42. 10.3390/molecules2309212010.3390/molecules23092120 ↗